RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.320
-0.080 (-5.71%)
At close: Jul 15, 2025, 4:00 PM
1.320
0.00 (0.02%)
After-hours: Jul 15, 2025, 4:52 PM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $48.28 million as of July 15, 2025. Its market cap has increased by 78.36% in one year.
Market Cap
48.28M
Enterprise Value
34.34M
1-Year Change
78.36%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $48.28M, a decrease of -29.67%. That is a compound annual growth rate of -8.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 51.20M | 65.37% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.22B |
| Johnson & Johnson | 375.44B |
| AbbVie | 336.48B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 271.62B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.99B |
| AstraZeneca | 218.74B |